Add Yahoo as a preferred source to see more of our stories on Google. Sickle cell disease reshapes healthy round blood cells into a sickled C-shape. As these sticky cells clump up, they can block ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine This voice experience is generated by AI. Learn more. This ...

Learn what sickle cell disease is, who it affects most, today’s treatment options, and how cost and inequities limit access. Sickle cell disease (SCD) is a complex inherited blood disorder that ...

Advances in sickle cell therapies, including gene editing, offer hope—but racial disparities, cost, and access barriers remain major challenges. Racial and ethnic disparities in health care persist in ...

13-year-old Rickey Buggs became the first commercial patient to receive a gene-editing treatment for sickle cell disease at ...

July 1 (Reuters) - The U.S. Food and Drug Administration approved expanded use of Vertex Pharmaceuticals' (VRTX.O), opens new tab gene therapy in children as young as two with inherited blood ...

Sickle cell disease causes premature aging of blood stem cells, which scientists may be able to address with a special class ...

Gene therapy has given sickle cell disease what medicine has long promised but rarely delivered: the possibility of a cure. Yet the slow uptake of Casgevy and Lyfgenia shows that even dazzling science ...

“Think of the blood vessels like a city highway,” says Elizabeth Margolskee, MD, MPH, a clinical pathologist and an associate professor of clinical pathology and laboratory medicine at the Perelman ...